Histone methyltransferase ash1l suppresses interleukin-6 production and inflammatory autoimmune diseases by inducing the ubiquitin-editing enzyme A20

Immunity

Volumn 39, Issue 3, 2013, Pages 470-481

  Xia, Meng ^a,b   Liu, Juan ^b   Wu, Xiaohui ^c   Liu, Shuxun ^b   Li, Gang ^c   Han, Chaofeng ^b   Song, Lijun ^b   Li, Zhiqing ^a   Wang, Qingqing ^a   Wang, Jianli ^a   Xu, Tian ^c   Cao, Xuetao ^a,b,d  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

^d INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ASH1L PROTEIN; BETA3 INTEGRIN; HISTONE H3; HISTONE METHYLTRANSFERASE; I KAPPA B ALPHA; I KAPPA B BETA; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; IMMUNOGLOBULIN A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; IMMUNOGLOBULIN M; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; AUTOINFLAMMATORY DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEACETYLATION; DISEASE PREDISPOSITION; ENZYME ACTIVITY; ESCHERICHIA COLI INFECTION; HISTONE MODIFICATION; MACROPHAGE; MALE; MEMBRANOUS GLOMERULONEPHRITIS; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROMOTER REGION; SEPSIS; SIGNAL TRANSDUCTION; UBIQUITINATION;

ANIMALS; AUTOIMMUNE DISEASES; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELLS, CULTURED; DNA-BINDING PROTEINS; HISTONES; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFLAMMATION; INTERLEUKIN-6; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MACROPHAGES; MICE; MICE, KNOCKOUT; NF-KAPPA B; PROMOTER REGIONS, GENETIC; RNA INTERFERENCE; RNA, SMALL INTERFERING; SEPSIS; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 6; TOLL-LIKE RECEPTORS; TUMOR NECROSIS FACTORS; UBIQUITIN; UBIQUITIN-PROTEIN LIGASES;

EID: 84884355331     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2013.08.016     Document Type: Article

References (41)

1. Ainbinder E., Revach M., Wolstein O., Moshonov S., Diamant N., Dikstein R. Mechanism of rapid transcriptional induction of tumor necrosis factor alpha-responsive genes by NF-kappaB. Mol. Cell. Biol. 2002, 22:6354-6362.
2. Allis C.D., Berger S.L., Cote J., Dent S., Jenuwien T., Kouzarides T., Pillus L., Reinberg D., Shi Y., Shiekhattar R., et al. New nomenclature for chromatin-modifying enzymes. Cell 2007, 131:633-636.
3. Alonzi T., Fattori E., Lazzaro D., Costa P., Probert L., Kollias G., De Benedetti F., Poli V., Ciliberto G. Interleukin 6 is required for the development of collagen-induced arthritis. J.Exp. Med. 1998, 187:461-468.
4. Austenaa L., Barozzi I., Chronowska A., Termanini A., Ostuni R., Prosperini E., Stewart A.F., Testa G., Natoli G. The histone methyltransferase Wbp7 controls macrophage function through GPI glycolipid anchor synthesis. Immunity 2012, 36:572-585.
5. Beisel C., Imhof A., Greene J., Kremmer E., Sauer F. Histone methylation by the Drosophila epigenetic transcriptional regulator Ash1. Nature 2002, 419:857-862.
6. Ben-Neriah Y., Karin M. Inflammation meets cancer, with NF-κB as the matchmaker. Nat. Immunol. 2011, 12:715-723.
7. Boone D.L., Turer E.E., Lee E.G., Ahmad R.C., Wheeler M.T., Tsui C., Hurley P., Chien M., Chai S., Hitotsumatsu O., et al. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat. Immunol. 2004, 5:1052-1060.
8. Byrd K.N., Shearn A. ASH1, a Drosophila trithorax group protein, is required for methylation of lysine 4 residues on histone H3. Proc. Natl. Acad. Sci. USA 2003, 100:11535-11540.
9. Chen Z.J. Ubiquitination in signaling to and activation of IKK. Immunol. Rev. 2012, 246:95-106.
10. Chen W., Han C., Xie B., Hu X., Yu Q., Shi L., Wang Q., Li D., Wang J., Zheng P., et al. Induction of Siglec-G by RNA viruses inhibits the innate immune response by promoting RIG-I degradation. Cell 2013, 152:467-478.
11. Coornaert B., Baens M., Heyninck K., Bekaert T., Haegman M., Staal J., Sun L., Chen Z.J., Marynen P., Beyaert R. T cell antigen receptorstimulation induces MALT1 paracaspase-mediated cleavage of the NF-kappaB inhibitor A20. Nat. Immunol. 2008, 9:263-271.
12. Ding S., Wu X., Li G., Han M., Zhuang Y., Xu T. Efficient transposition of the piggyBac (PB) transposon in mammalian cells and mice. Cell 2005, 122:473-483.
13. Feinberg A.P. Phenotypic plasticity and the epigenetics of human disease. Nature 2007, 447:433-440.
14. Gregory G.D., Vakoc C.R., Rozovskaia T., Zheng X., Patel S., Nakamura T., Canaani E., Blobel G.A. Mammalian ASH1L is a histone methyltransferase that occupies the transcribed region of active genes. Mol. Cell. Biol. 2007, 27:8466-8479.
15. Han C., Jin J., Xu S., Liu H., Li N., Cao X. Integrin CD11b negatively regulates TLR-triggered inflammatory responses by activating Syk and promoting degradation of MyD88 and TRIF via Cbl-b. Nat. Immunol. 2010, 11:734-742.
16. Hu H., Brittain G.C., Chang J.H., Puebla-Osorio N., Jin J., Zal A., Xiao Y., Cheng X., Chang M., Fu Y.X., et al. OTUD7B controls non-canonical NF-κB activation through deubiquitination of TRAF3. Nature 2013, 494:371-374.
17. Hutti J.E., Turk B.E., Asara J.M., Ma A., Cantley L.C., Abbott D.W. IkappaB kinase β phosphorylates the K63 deubiquitinase A20 to cause feedback inhibition of the NF-kappaB pathway. Mol. Cell. Biol. 2007, 27:7451-7461.
18. Kawagoe T., Takeuchi O., Takabatake Y., Kato H., Isaka Y., Tsujimura T., Akira S. TANK is a negative regulator of Toll-like receptor signaling and is critical for the prevention of autoimmune nephritis. Nat. Immunol. 2009, 10:965-972.
19. Kawai T., Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 2010, 11:373-384.
20. Kayama H., Ramirez-Carrozzi V.R., Yamamoto M., Mizutani T., Kuwata H., Iba H., Matsumoto M., Honda K., Smale S.T., Takeda K. Class-specific regulation of pro-inflammatory genes by MyD88 pathways and IkappaBzeta. J.Biol. Chem. 2008, 283:12468-12477.
21. Koch M.W., Metz L.M., Kovalchuk O. Epigenetic changes in patients with multiple sclerosis. Nat Rev Neurol 2013, 9:35-43.
22. Krivtsov A.V., Armstrong S.A. MLL translocations, histone modifications and leukaemia stem-cell development. Nat. Rev. Cancer 2007, 7:823-833.
23. Liew F.Y., Xu D., Brint E.K., O'Neill L.A. Negative regulation oftoll-like receptor-mediated immune responses. Nat. Rev. Immunol. 2005, 5:446-458.
24. Liu J., Lee W., Jiang Z., Chen Z., Jhunjhunwala S., Haverty P.M., Gnad F., Guan Y., Gilbert H.N., Stinson J., et al. Genome and transcriptome sequencing of lung cancers reveal diverse mutational and splicing events. Genome Res. 2012, 22:2315-2327.
25. Ma A., Malynn B.A. A20: linking a complex regulator of ubiquitylation to immunity and human disease. Nat. Rev. Immunol. 2012, 12:74-85.
26. Marshak-Rothstein A. Toll-like receptors in systemic autoimmune disease. Nat. Rev. Immunol. 2006, 6:823-835.
27. Matmati M., Jacques P., Maelfait J., Verheugen E., Kool M., Sze M., Geboes L., Louagie E., Mc Guire C., Vereecke L., et al. A20 (TNFAIP3) deficiency in myeloid cells triggers erosive polyarthritis resembling rheumatoid arthritis. Nat. Genet. 2011, 43:908-912.
28. Miao C.G., Yang Y.Y., He X., Li J. New advances of DNA methylation and histone modifications in rheumatoid arthritis, with special emphasis on MeCP2. Cell. Signal. 2013, 25:875-882.
29. Nakata Y., Brignier A.C., Jin S., Shen Y., Rudnick S.I., Sugita M., Gewirtz A.M. c-Myb, Menin, GATA-3, and MLL form a dynamic transcription complex that plays a pivotal role in human T helper type 2 cell development. Blood 2010, 116:1280-1290.
30. Netea M.G., Wijmenga C., O'Neill L.A. Genetic variation in Toll-like receptors and disease susceptibility. Nat. Immunol. 2012, 13:535-542.
31. Portela A., Esteller M. Epigenetic modifications and human disease. Nat. Biotechnol. 2010, 28:1057-1068.
32. Schuettengruber B., Chourrout D., Vervoort M., Leblanc B., Cavalli G. Genome regulation by polycomb and trithorax proteins. Cell 2007, 128:735-745.
33. Shearn A., Hersperger G., Hersperger E. Genetic analysis of two allelic temperature-sensitive mutants of Drosophila melanogaster both of which are zygotic and maternal-effect lethals. Genetics 1978, 89:341-353.
34. Shimane K., Kochi Y., Horita T., Ikari K., Amano H., Hirakata M., Okamoto A., Yamada R., Myouzen K., Suzuki A., et al. The association of a nonsynonymous single-nucleotide polymorphism in TNFAIP3 with systemic lupus erythematosus and rheumatoid arthritis in the Japanese population. Arthritis Rheum. 2010, 62:574-579.
35. Takeuchi O., Akira S. Pattern recognition receptors and inflammation. Cell 2010, 140:805-820.
36. Tanaka T., Kishimoto T. Immunotherapeutic implication of IL-6 blockade. Immunotherapy 2012, 4:87-105.
37. Tanaka Y., Nakayama Y., Taniguchi M., Kioussis D. Regulation of early Tcell development by the PHD finger of histone lysine methyltransferase ASH1. Biochem. Biophys. Res. Commun. 2008, 365:589-594.
38. Tanaka Y., Kawahashi K., Katagiri Z., Nakayama Y., Mahajan M., Kioussis D. Dual function of histone H3 lysine 36 methyltransferase ASH1 in regulation of Hox gene expression. PLoS ONE 2011, 6:e28171.
39. Wang X., Zhu K., Li S., Liao Y., Du R., Zhang X., Shu H.B., Guo A.Y., Li L., Wu M. MLL1, a H3K4 methyltransferase, regulates the TNFα-stimulated activation of genes downstream of NF-κB. J.Cell Sci. 2012, 125:4058-4066.
40. Xu S., Liu X., Bao Y., Zhu X., Han C., Zhang P., Zhang X., Li W., Cao X. Constitutive MHC class I molecules negatively regulate TLR-triggered inflammatory responses via the Fps-SHP-2 pathway. Nat. Immunol. 2012, 13:551-559.
41. Zucchelli S., Holler P., Yamagata T., Roy M., Benoist C., Mathis D. Defective central tolerance induction in NOD mice: genomics and genetics. Immunity 2005, 22:385-396.